[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 US Oncology Testing Market Shares and Sales Segment Forecasts By Assay

September 2018 | 40 pages | ID: 2D9642E0072EN
Venture Planning Group

US$ 850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Contains 40 pages and 7 tables
BUSINESS ENVIRONMENT

1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
  a. Chronic Illness
  b. Disease Incidence
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
11. Laboratory Regulations

MARKET STRUCTURE

1. Centralized Testing
  a. Hospitals
  b. Commercial/Private Laboratories
2. Decentralized Testing
  a. Physician Offices/Group Practices
  b. Cancer Clinics
  c. Point of Care Testing
  d. Other Decentralized Testing Locations

MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES

LIST OF TABLE

Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment

LIST OF TABLE (CONTINUED)

AFP Testing: Market Shares of Major Suppliers
CA 15-3/27-29 Testing: Market Shares of Major Suppliers
CA 19-9 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers


More Publications